The international antidoping system and why it works.

In the days leading up to the 2008 Olympic Games in Beijing, a number of scientific journals published special issues (1)(2) or critical commentaries and opinion pieces regarding the antidoping movement. For example, an analysis of antidoping policy by Kayser and Smith (3) presented criticisms based on ethical arguments (4). On the other hand, equally persuasive ethical arguments supporting antidoping policies were reported by Murray (5). In addition, the public statements released by the defense team before each of the 2 arbitration hearings for Tour De France winner Floyd Landis, at which he was convicted of committing a doping violation, vehemently attacked the laboratory and the staff that performed the test. These public attacks were by advocates for the defendant, and the antidoping rules prevented a response to these charges. My purpose here is to provide an overview of how the current antidoping rules came into effect, to review some of the science underlying the antidoping rules, and to discuss a few of the cases decided by the Court of Arbitration in Sport (CAS).1 The fight against performance-enhancing substances began in the 1920s, long before there were testing methods for the prohibited substances. For years, the leaders of sport went it alone in this fight. Some critics argued, and continue to argue, that sport leaders have an issue similar to the “fox guarding the henhouse” when it comes to overseeing drug-testing programs. A major shift occurred in 1999, when the World Anti-Doping Agency (WADA) was formed as an independent body to harmonize antidoping practices, and independent national antidoping organizations such as the Australian Sport Drug Agency, the Canadian Center for Ethics in Sport, and the United States Anti-Doping Agency (USADA) began to emerge. WADA was established as a Swiss foundation with the support of intergovernmental bodies, governments, …

[1]  J. Munby,et al.  Drugs in Sport , 2010, Scottish medical journal.

[2]  L. Bowers The analytical chemistry of drug monitoring in athletes. , 2009, Annual review of analytical chemistry.

[3]  A. Bergmann,et al.  High-sensitivity chemiluminescence immunoassays for detection of growth hormone doping in sports. , 2009, Clinical chemistry.

[4]  D. Cowan,et al.  Doping in sport—1. Excretion of 19-norandrosterone by healthy women, including those using contraceptives containing norethisterone , 2009, Steroids.

[5]  Donald A. Berry,et al.  The science of doping , 2008, Nature.

[6]  Aaron C. T. Smith,et al.  Globalisation of anti-doping: the reverse side of the medal , 2008, BMJ : British Medical Journal.

[7]  P. Sönksen,et al.  The effect of sports injury on insulin-like growth factor-I and type 3 procollagen: implications for detection of growth hormone abuse in athletes. , 2008, The Journal of clinical endocrinology and metabolism.

[8]  U. Flenker,et al.  The application of carbon isotope ratio mass spectrometry to doping control. , 2008, Journal of mass spectrometry : JMS.

[9]  P. Hemmersbach History of mass spectrometry at the Olympic Games. , 2008, Journal of mass spectrometry : JMS.

[10]  Christiane Ayotte Suivi des profils de strodes urinaires dans le contrle du dopage des sportifs , 2008 .

[11]  Martial Saugy,et al.  From population- to subject-based limits of T/E ratio to detect testosterone abuse in elite sports. , 2008, Forensic science international.

[12]  M. Majumder The Oxford Handbook of Bioethics , 2007 .

[13]  O. Rabin,et al.  The WADA Proficiency Testing Program as an integral part of the fight against doping in sport , 2007 .

[14]  M. Thevis,et al.  Proteases in Doping Control Analysis , 2007, International journal of sports medicine.

[15]  Martial Saugy,et al.  Bayesian detection of abnormal values in longitudinal biomarkers with an application to T/E ratio. , 2007, Biostatistics.

[16]  B. Kayser,et al.  Current anti-doping policy: a critical appraisal , 2007, BMC medical ethics.

[17]  W. Franke,et al.  Hormonal doping and androgenization of athletes: a secret program of the German Democratic Republic government. , 1997, Clinical chemistry.

[18]  C. Ayotte,et al.  Testing for natural and synthetic anabolic agents in human urine. , 1996, Journal of chromatography. B, Biomedical applications.

[19]  R. Hider,et al.  New decision limits and quality-control material for detecting human chorionic gonadotropin misuse in sports. , 1994, Clinical chemistry.

[20]  G. Tucker,et al.  Routine detection and identification in urine of stimulants and other drugs, some of which may be used to modify performance in sport , 1967, The Journal of pharmacy and pharmacology.

[21]  Paul Marriott-Lloyd International Convention against Doping in Sport , 2010 .

[22]  Andrew J. Hutt,et al.  Recent Advances in Doping Analysis , 2002 .

[23]  D. Mitchell A level playing field. , 1993, Journal of the Mississippi State Medical Association.